Researchers say approach could be useful for both initial treatment of bladder cancer as well as treatment refractory subsets of tumors.
Bladder cancer remains one of the most frequently diagnosed urologic malignancies worldwide, imposing a heavy and persistent ...
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results